Hanania NA - Search Results

1

Long-term safety of nebulized formoterol: results of a twelve-month open-label clinical trial.

Donohue JF, Hanania NA, Fogarty C, Campbell SC, Rinehart M, Denis-Mize K. Donohue JF, et al. Among authors: hanania na. Ther Adv Respir Dis. 2008 Aug;2(4):199-208. doi: 10.1177/1753465808093934. Ther Adv Respir Dis. 2008. PMID: 19124372 Free article. Clinical Trial.

2

Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators.

Hanania NA, Donohue JF. Hanania NA, et al. Proc Am Thorac Soc. 2007 Oct 1;4(7):526-34. doi: 10.1513/pats.200701-016FM. Proc Am Thorac Soc. 2007. PMID: 17878465 Review.

3

Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: a 2-week, multicenter, randomized, open-label study.

Donohue JF, Hanania NA, Ciubotaru RL, Noe L, Pasta DJ, Schaefer K, Claus R, Andrews WT, Roach J. Donohue JF, et al. Among authors: hanania na. Clin Ther. 2008;30 Spec No:989-1002. doi: 10.1016/j.clinthera.2008.06.010. Clin Ther. 2008. PMID: 18640474 Clinical Trial.

4

Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.

Donohue JF, Hanania NA, Sciarappa KA, Goodwin E, Grogan DR, Baumgartner RA, Hanrahan JP. Donohue JF, et al. Among authors: hanania na. Ther Adv Respir Dis. 2008 Apr;2(2):37-48. doi: 10.1177/1753465808089455. Ther Adv Respir Dis. 2008. PMID: 19124357 Free article. Clinical Trial.

5

Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ).

Bailey WC, Sciurba FC, Hanania NA, Donohue JF, Ferguson GT, Zibrak JD, Sharafkhaneh A, Marcus P, Rosa K, Piault EC, Martinez FJ. Bailey WC, et al. Among authors: hanania na. Prim Care Respir J. 2009 Sep;18(3):198-207. doi: 10.4104/pcrj.2009.00032. Prim Care Respir J. 2009. PMID: 19492178 Free PMC article.

6

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

Hanania NA, Boota A, Kerwin E, Tomlinson L, Denis-Mize K. Hanania NA, et al. Drugs. 2009 Jun 18;69(9):1205-16. doi: 10.2165/00003495-200969090-00005. Drugs. 2009. PMID: 19537837 Clinical Trial.

7

Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease.

Tashkin DP, Hanania NA, McGinty J, Denis-Mize K, Chaudry I. Tashkin DP, et al. Among authors: hanania na. Adv Ther. 2009 Nov;26(11):1024-34. doi: 10.1007/s12325-009-0080-z. Epub 2009 Dec 2. Adv Ther. 2009. PMID: 19953349

8

Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.

Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP, Decramer M; Uplift Investigators. Troosters T, et al. Eur Respir J. 2010 Jul;36(1):65-73. doi: 10.1183/09031936.00127809. Epub 2010 Feb 25. Eur Respir J. 2010. PMID: 20185426 Free article. Clinical Trial.

9

The safety and efficacy of arformoterol and formoterol in COPD.

Hanania NA, Donohue JF, Nelson H, Sciarappa K, Goodwin E, Baumgartner RA, Hanrahan JP. Hanania NA, et al. COPD. 2010 Feb;7(1):17-31. doi: 10.3109/15412550903499498. COPD. 2010. PMID: 20214460 Free article. Clinical Trial.

10

Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ).

Hanania NA, Mannino DM, Yawn BP, Mapel DW, Martinez FJ, Donohue JF, Kosinski M, Rendas-Baum R, Mintz M, Samuels S, Jhingran P, Dalal AA. Hanania NA, et al. Respir Med. 2010 Aug;104(8):1160-70. doi: 10.1016/j.rmed.2010.02.009. Epub 2010 Mar 11. Respir Med. 2010. PMID: 20226647 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

339 results

Search Page

Filters